BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17303660)

  • 1. Alteration of glucose homeostasis in V1a vasopressin receptor-deficient mice.
    Aoyagi T; Birumachi J; Hiroyama M; Fujiwara Y; Sanbe A; Yamauchi J; Tanoue A
    Endocrinology; 2007 May; 148(5):2075-84. PubMed ID: 17303660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperammonaemia in V1a vasopressin receptor knockout mice caused by the promoted proteolysis and reduced intrahepatic blood volume.
    Hiroyama M; Aoyagi T; Fujiwara Y; Oshikawa S; Sanbe A; Endo F; Tanoue A
    J Physiol; 2007 Jun; 581(Pt 3):1183-92. PubMed ID: 17379633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both V(1A) and V(1B) vasopressin receptors deficiency result in impaired glucose tolerance.
    Nakamura K; Aoyagi T; Hiroyama M; Kusakawa S; Mizutani R; Sanbe A; Yamauchi J; Kamohara M; Momose K; Tanoue A
    Eur J Pharmacol; 2009 Jun; 613(1-3):182-8. PubMed ID: 19375419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressin regulation of blood pressure and volume: findings from V1a receptor-deficient mice.
    Aoyagi T; Koshimizu TA; Tanoue A
    Kidney Int; 2009 Nov; 76(10):1035-9. PubMed ID: 19693000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and chronic hyperglycemic effects of vasopressin in normal rats: involvement of V
    Taveau C; Chollet C; Bichet DG; Velho G; Guillon G; Corbani M; Roussel R; Bankir L; Melander O; Bouby N
    Am J Physiol Endocrinol Metab; 2017 Mar; 312(3):E127-E135. PubMed ID: 27998960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypermetabolism of fat in V1a vasopressin receptor knockout mice.
    Hiroyama M; Aoyagi T; Fujiwara Y; Birumachi J; Shigematsu Y; Kiwaki K; Tasaki R; Endo F; Tanoue A
    Mol Endocrinol; 2007 Jan; 21(1):247-58. PubMed ID: 17021052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased susceptibility to salt-induced hypertension in subtotally nephrectomized mice lacking the vasopressin V1a receptor.
    Oikawa R; Hosoda C; Nasa Y; Daicho T; Tanoue A; Tsujimoto G; Takagi N; Tanonaka K; Takeo S
    Cardiovasc Res; 2010 Jul; 87(1):187-94. PubMed ID: 20118201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired arginine-vasopressin-induced aldosterone release from adrenal gland cells in mice lacking the vasopressin V1A receptor.
    Birumachi J; Hiroyama M; Fujiwara Y; Aoyagi T; Sanbe A; Tanoue A
    Eur J Pharmacol; 2007 Jul; 566(1-3):226-30. PubMed ID: 17449028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasopressin regulates the renin-angiotensin-aldosterone system via V1a receptors in macula densa cells.
    Aoyagi T; Izumi Y; Hiroyama M; Matsuzaki T; Yasuoka Y; Sanbe A; Miyazaki H; Fujiwara Y; Nakayama Y; Kohda Y; Yamauchi J; Inoue T; Kawahara K; Saito H; Tomita K; Nonoguchi H; Tanoue A
    Am J Physiol Renal Physiol; 2008 Jul; 295(1):F100-7. PubMed ID: 18448596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice.
    Hiroyama M; Wang S; Aoyagi T; Oikawa R; Sanbe A; Takeo S; Tanoue A
    Eur J Pharmacol; 2007 Mar; 559(2-3):89-97. PubMed ID: 17275806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin receptor subtype-2-deficient mice with diet-induced obesity have hyperglycemia, nonfasting hyperglucagonemia, and decreased hepatic glycogen deposition.
    Singh V; Grötzinger C; Nowak KW; Zacharias S; Göncz E; Pless G; Sauer IM; Eichhorn I; Pfeiffer-Guglielmi B; Hamprecht B; Wiedenmann B; Plöckinger U; Strowski MZ
    Endocrinology; 2007 Aug; 148(8):3887-99. PubMed ID: 17525126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced glucose tolerance in the Brattleboro rat.
    Nakamura K; Yamashita T; Fujiki H; Aoyagi T; Yamauchi J; Mori T; Tanoue A
    Biochem Biophys Res Commun; 2011 Feb; 405(1):64-7. PubMed ID: 21215256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. V1a vasopressin receptors maintain normal blood pressure by regulating circulating blood volume and baroreflex sensitivity.
    Koshimizu TA; Nasa Y; Tanoue A; Oikawa R; Kawahara Y; Kiyono Y; Adachi T; Tanaka T; Kuwaki T; Mori T; Takeo S; Okamura H; Tsujimoto G
    Proc Natl Acad Sci U S A; 2006 May; 103(20):7807-12. PubMed ID: 16682631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of amino acid residues that direct differential ligand selectivity of mammalian and nonmammalian V1a type receptors for arginine vasopressin and vasotocin. Insights into molecular coevolution of V1a type receptors and their ligands.
    Acharjee S; Do-Rego JL; Oh DY; Ahn RS; Choe H; Vaudry H; Kim K; Seong JY; Kwon HB
    J Biol Chem; 2004 Dec; 279(52):54445-53. PubMed ID: 15475353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ablation of Sax2 gene expression prevents diet-induced obesity.
    Simon R; Britsch S; Bergemann A
    FEBS J; 2011 Jan; 278(2):371-82. PubMed ID: 21126319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered cardiovascular regulation in arginine vasopressin-overexpressing transgenic rat.
    Tachikawa K; Yokoi H; Nagasaki H; Arima H; Murase T; Sugimura Y; Miura Y; Hirabayashi M; Oiso Y
    Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1161-6. PubMed ID: 12915399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Energy-restricted high-fat diets only partially improve markers of systemic and adipose tissue inflammation.
    Kalupahana NS; Voy BH; Saxton AM; Moustaid-Moussa N
    Obesity (Silver Spring); 2011 Feb; 19(2):245-54. PubMed ID: 20847734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage migration inhibitory factor deficiency leads to age-dependent impairment of glucose homeostasis in mice.
    Serre-Beinier V; Toso C; Morel P; Gonelle-Gispert C; Veyrat-Durebex C; Rohner-Jeanrenaud F; Calandra T; Roger T; James RW; Montet X; Bühler L; Bosco D; Berney T
    J Endocrinol; 2010 Sep; 206(3):297-306. PubMed ID: 20566490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infliximab restores glucose homeostasis in an animal model of diet-induced obesity and diabetes.
    Araújo EP; De Souza CT; Ueno M; Cintra DE; Bertolo MB; Carvalheira JB; Saad MJ; Velloso LA
    Endocrinology; 2007 Dec; 148(12):5991-7. PubMed ID: 17761768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal vasopressin alleviates formalin-induced nociception by enhancing GABAA receptor function in mice.
    Peng F; Qu ZW; Qiu CY; Liao M; Hu WP
    Neurosci Lett; 2015 Apr; 593():61-5. PubMed ID: 25782631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.